| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Sorrento Therapeutics, Inc. (SRNE) has 0 insiders with recent SEC Form 4 filings, including 3 buys and 9 sells. SRNE is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 3, 2017 | Wu Yue Alexander | Director | Buy | 5,000 | $5.15 | $25,750.00 | New | |
| Feb 3, 2017 | Janda Kim | Director | Buy | 3,000 | $5.15 | $15,450.00 | New | |
| Feb 3, 2017 | Shah Jaisim | Director | Buy | 10,000 | $5.15 | $51,500.00 | +10.8% | |
| Jul 7, 2016 | Soon-Shiong Patrick | Former 10% Owner | Sell | 7,878,098 | $0.00 | - | -100% | |
| Jun 29, 2016 | Soon-Shiong Patrick | 10% Owner | Sell | 3,400 | $5.82 | $19,784.60 | - | |
| Jun 23, 2016 | Soon-Shiong Patrick | 10% Owner | Sell | 6,901 | $5.85 | $40,398.45 | - | |
| Jun 15, 2016 | Soon-Shiong Patrick | 10% Owner | Sell | 19,836 | $5.87 | $116,476.99 | -0.3% | |
| Jun 14, 2016 | Soon-Shiong Patrick | 10% Owner | Sell | 53,764 | $6.14 | $329,884.65 | -3.6% | |
| Mar 7, 2016 | Soon-Shiong Patrick | 10% Owner | Sell | 100,000 | $6.19 | $619,499.00 | -5.8% | |
| Sep 18, 2015 | Uy George | See Remarks | Sell | 47,500 | $0.00 | - | -19.1% |